Limited utility of RECIST 1.1 in predicting pathologic response to neoadjuvant radiotherapy in myxoid liposarcoma

Yuri Velichko et al.

RSNA 2024

BibTeX
RSNA 2024 conference logo

Abstract

An abstract is not available in the lab archive.

Cite this work

Yuri Velichko et al. (2024). Limited utility of RECIST 1.1 in predicting pathologic response to neoadjuvant radiotherapy in myxoid liposarcoma. RSNA 2024

BibTeX